Merck Q2 net down 38.87% at Rs. 15.77 crore

October 23, 2013 04:55 pm | Updated September 26, 2016 11:31 pm IST - New Delhi

FILE - In this file photo made April 15, 2009, the Merck logo is seen in the lobby of Merck & Company, Inc.'s world headquarters in Whitehouse Station, N.J. Federal health officials said Monday, April 25, 2011, a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years.  (AP Photo/Mel Evans, File)

FILE - In this file photo made April 15, 2009, the Merck logo is seen in the lobby of Merck & Company, Inc.'s world headquarters in Whitehouse Station, N.J. Federal health officials said Monday, April 25, 2011, a highly-anticipated drug to treat hepatitis C made by Merck appears to cure more patients in less time than established drugs that have been used for 20 years. (AP Photo/Mel Evans, File)

Pharmaceutical company Merck Ltd on Wednesday reported 38.87 per cent decline in net profit at Rs. 15.77 crore for the second quarter ended September 30, 2013, on the account of increase in expenses.

The company has reported net profit of Rs. 25.80 crore in the same quarter a year ago.

Net sales in the quarter under review were at Rs. 201.81 crore, an increase of 11.37 per cent compared with Rs. 181.2 in the corresponding quarter in the previous year, the company said in a BSE filing.

Overall expenses during the quarter were at Rs. 188.16 crore, an increase of 21.95 per cent as against Rs. 154.29 crore in the same quarter last year.

The company’s shares were trading at Rs. 573 per scrip during the afternoon trade, down 0.39 per cent from its previous close, on the BSE.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.